$VEEE
Twin Vee PowerCats, Co. Stock $veee

$veee Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000173112222001893 Filed on November 09, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$8.770M	$8.812M	$4.118M
YoY Change	70.27%	113.98%	64.85%
Cost Of Revenue	$7.329M	$5.478M	$2.508M
YoY Change	122.83%	118.4%	39.48%
Gross Profit	$1.441M	$3.334M	$1.610M
YoY Change	-22.59%	107.08%	130.03%
Gross Profit Margin	16.43%	37.84%	39.1%
Selling, General & Admin	$4.643M	$707.3K	$513.0K
YoY Change	55.23%	37.88%	104.07%
% of Gross Profit	322.19%	21.21%	31.86%
Research & Development	$261.2K	$283.9K	$61.09K
YoY Change	74.14%	364.78%
% of Gross Profit	18.13%	8.52%	3.79%
Depreciation & Amortization	$181.2K	$172.6K	$31.09K
YoY Change	172.83%	455.14%	-5.98%
% of Gross Profit	12.58%	5.18%	1.93%
Operating Expenses	$5.086M	$4.191M	$1.933M
YoY Change	58.55%	116.86%	103.97%
Operating Profit	-$3.645M	-$857.0K	-$322.5K
YoY Change	170.77%	165.7%	30.29%
Interest Expense	$380.00	$52.88K	-$60.90K
YoY Change	-100.52%	-186.83%
% of Operating Profit
Other Income/Expense, Net	$122.1K	-$30.15K	-$60.74K
YoY Change	31217.95%	-50.37%	-229.15%
Pretax Income	-$3.176M	-$887.1K	-$383.3K
YoY Change	291.87%	131.45%
Income Tax
% Of Pretax Income
Net Earnings	-$2.707M	-$887.1K	-$383.3K
YoY Change	233.99%	131.45%	91.14%
Net Earnings / Revenue	-30.87%	-10.07%	-9.31%
Basic Earnings Per Share		-$0.10
Diluted Earnings Per Share	-$0.29	-$99.81K	-$61.01K
COMMON SHARES
Basic Shares Outstanding	9.520M shares	7.000M shares	7.000M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$26.43M	$22.89M	$15.07M
YoY Change	102.68%	51.87%
Cash & Equivalents	$23.50M	$19.98M	$8.979M
Short-Term Investments	$2.928M	$2.911M	$6.091M
Other Short-Term Assets	$882.4K	$1.510M	$685.2K
YoY Change	-12.57%	120.41%
Inventory	$4.008M	$4.393M	$2.452M
Prepaid Expenses
Receivables	$14.17K	$1.610K	$212.9K
Other Receivables	$0.00	$368.1K	$306.9K
Total Short-Term Assets	$29.89M	$26.25M	$15.63M
YoY Change	128.61%	67.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.536M	$4.775M	$2.231M
YoY Change	92.01%	114.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$1.446M	$2.911M	$3.093M
YoY Change	-52.86%	-5.88%
Other Assets	$32.52K	$25.00K	$25.00K
YoY Change	30.08%	0.0%
Total Long-Term Assets	$8.344M	$8.975M	$6.995M
YoY Change	10.87%	28.3%
TOTAL ASSETS
Total Short-Term Assets	$29.89M	$26.25M	$15.63M
Total Long-Term Assets	$8.344M	$8.975M	$6.995M
Total Assets	$38.23M	$35.22M	$22.63M
YoY Change	85.6%	55.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.066M	$1.928M	$1.688M
YoY Change	72.02%	14.21%
Accrued Expenses	$1.241M	$538.3K	$492.2K
YoY Change	171.61%	9.37%
Deferred Revenue	$5.300K	$1.027M	$162.6K
YoY Change	-62.41%	531.21%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.791M	$3.996M	$2.897M
YoY Change	75.89%	37.9%
LONG-TERM LIABILITIES
Long-Term Debt	$499.9K	$499.9K	$1.108M
YoY Change	0.0%	-54.89%
Other Long-Term Liabilities	$919.6K	$949.5K	$1.336M
YoY Change	-26.08%	-28.95%
Total Long-Term Liabilities	$1.420M	$1.449M	$2.445M
YoY Change	-18.61%	-40.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.791M	$3.996M	$2.897M
Total Long-Term Liabilities	$1.420M	$1.449M	$2.445M
Total Liabilities	$5.211M	$5.445M	$5.342M
YoY Change	33.62%	1.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$7.155M	-$4.448M	-$1.207M
YoY Change	254.63%	268.48%
Common Stock	$9.520K	$7.020K	$7.000K
YoY Change	36.0%	0.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$28.44M	$24.72M	$17.29M
YoY Change
Total Liabilities & Shareholders Equity	$38.23M	$35.22M	$22.63M
YoY Change	85.6%	55.66%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$2.707M	-$887.1K	-$383.3K
YoY Change	233.99%	131.45%	91.14%
Depreciation, Depletion And Amortization	$181.2K	$172.6K	$31.09K
YoY Change	172.83%	455.14%	-5.98%
Cash From Operating Activities	-$1.562M	-$1.388M	-$748.5K
YoY Change	29.69%	85.46%
INVESTING ACTIVITIES
Capital Expenditures	$971.5K	-$584.7K	-$616.8K
YoY Change	-235.14%	-5.21%
Acquisitions
YoY Change
Other Investing Activities	$87.48K	$1.000M	-$6.101M
YoY Change	1685.31%	-116.39%
Cash From Investing Activities	-$884.0K	$415.3K	-$6.718M
YoY Change	23.82%	-106.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.971M	15.04M	16.04M
YoY Change	-7082.13%	-6.24%
NET CHANGE
Cash From Operating Activities	-1.562M	-1.388M	-748.5K
Cash From Investing Activities	-884.0K	415.3K	-6.718M
Cash From Financing Activities	5.971M	15.04M	16.04M
Net Change In Cash	3.525M	14.07M	8.572M
YoY Change	-275.96%	64.08%
FREE CASH FLOW
Cash From Operating Activities	-$1.562M	-$1.388M	-$748.5K
Capital Expenditures	$971.5K	-$584.7K	-$616.8K
Free Cash Flow	-$2.533M	-$803.4K	-$131.7K
YoY Change	422.05%	510.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001855509
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2022Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent		usd
CY2022Q3	us-gaap	Other Loans Payable OtherLoansPayable		usd
CY2021Q4	us-gaap	Other Loans Payable OtherLoansPayable		usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2021Q3	us-gaap	Interest And Other Income InterestAndOtherIncome		usd
	us-gaap	Interest And Other Income InterestAndOtherIncome		usd
CY2022Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2021Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets		usd
CY2022Q3	us-gaap	Gain On Business Interruption Insurance Recovery GainOnBusinessInterruptionInsuranceRecovery		usd
CY2021Q3	us-gaap	Gain On Business Interruption Insurance Recovery GainOnBusinessInterruptionInsuranceRecovery		usd
	us-gaap	Gain On Business Interruption Insurance Recovery GainOnBusinessInterruptionInsuranceRecovery		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
	tvpc	Net Sale Of Investment In Trading Marketable Securities NetSaleOfInvestmentInTradingMarketableSecurities		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Deferred Finance Costs Ownshare Lending Arrangement Issuance Costs Adjustment DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment		usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt		usd
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	tvpc	Increase In Rightofuse Asset And Lease Liability IncreaseInRightofuseAssetAndLeaseLiability		usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods		usd
CY2022Q3	us-gaap	Accrued Exchange Fee Rebate Current AccruedExchangeFeeRebateCurrent		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40623
	dei	Entity Registrant Name EntityRegistrantName	TWIN VEE POWERCATS CO.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-1417610
CY2022Q3	us-gaap	Due To Affiliate Current DueToAffiliateCurrent	115043	usd
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3101 S. US-1
	dei	Entity Address City Or Town EntityAddressCityOrTown	Ft. Pierce
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	34982
	dei	City Area Code CityAreaCode	(772)
	dei	Local Phone Number LocalPhoneNumber	429-2525
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	VEEE
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9520000	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19975562	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6975302	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1610	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5137	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2996960	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	4393238	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1799769	usd
CY2022Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts	10000	usd
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	105500	usd
CY2022Q3	us-gaap	Due From Affiliate Current DueFromAffiliateCurrent	368093	usd
CY2021Q4	us-gaap	Due From Affiliate Current DueFromAffiliateCurrent	286922	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1500153	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	903756	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	26248656	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	13073346	usd
CY2022Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	2910936	usd
CY2021Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	3067137	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4774839	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2883171	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1264259	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1550530	usd
CY2022Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	25000	usd
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	25000	usd
CY2022Q3	us-gaap	Assets Assets	35223690	usd
CY2021Q4	us-gaap	Assets Assets	20599184	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1927656	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1200861	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	538312	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	456814	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1026580	usd
CY2021Q4	us-gaap	Due To Affiliate Current DueToAffiliateCurrent	115043	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	14100	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	387993	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	368602	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3995584	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2155420	usd
CY2022Q3	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	499900	usd
CY2021Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	499900	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	949495	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1244164	usd
CY2022Q3	us-gaap	Liabilities Liabilities	5444979	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3899484	usd
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7020000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7020000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7000000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7000000	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	7020	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	29165138	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18710256	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4447684	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2017556	usd
CY2022Q3	us-gaap	Minority Interest MinorityInterest	5054237	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29778711	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16699700	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35223690	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20599184	usd
CY2022Q3	us-gaap	Revenues Revenues	8812021	usd
CY2021Q3	us-gaap	Revenues Revenues	4118246	usd
	us-gaap	Revenues Revenues	23217634	usd
	us-gaap	Revenues Revenues	10623460	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	5477947	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	2508170	usd
	us-gaap	Cost Of Revenue CostOfRevenue	14001994	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6209334	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	3334074	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	1610076	usd
	us-gaap	Gross Profit GrossProfit	9215640	usd
	us-gaap	Gross Profit GrossProfit	4414126	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	707322	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	512982	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2027387	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1090583	usd
CY2022Q3	us-gaap	Salaries And Wages SalariesAndWages	2891863	usd
CY2021Q3	us-gaap	Salaries And Wages SalariesAndWages	1222062	usd
	us-gaap	Salaries And Wages SalariesAndWages	7938954	usd
	us-gaap	Salaries And Wages SalariesAndWages	3197476	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	135311	usd
CY2021Q3	us-gaap	Professional Fees ProfessionalFees	105384	usd
	us-gaap	Professional Fees ProfessionalFees	573592	usd
	us-gaap	Professional Fees ProfessionalFees	217592	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	172602	usd
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	31091	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	372511	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	132089	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	283936	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	61091	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	680288	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	61091	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	4191034	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	1932610	usd
	us-gaap	Operating Expenses OperatingExpenses	11592732	usd
	us-gaap	Operating Expenses OperatingExpenses	4698831	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-856960	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-322534	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2377092	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-284705	usd
CY2022Q3	us-gaap	Other Income OtherIncome	29764	usd
CY2021Q3	us-gaap	Other Income OtherIncome	148	usd
	us-gaap	Other Income OtherIncome	32994	usd
	us-gaap	Other Income OtherIncome	148	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	52878	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	50315	usd
	us-gaap	Interest Expense InterestExpense	136434	usd
	us-gaap	Interest Expense InterestExpense	85468	usd
CY2022Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	30958	usd
	us-gaap	Interest And Other Income InterestAndOtherIncome	63883	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-49990	usd
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-254600	usd
	us-gaap	Gain On Business Interruption Insurance Recovery GainOnBusinessInterruptionInsuranceRecovery	434724	usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	-37993	usd
CY2021Q3	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	-10576	usd
	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	-150569	usd
	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	-10576	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-30149	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-60743	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-240116	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	84228	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-887109	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-383277	usd
	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-2617208	usd
	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-200477	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-887109	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-383277	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2617208	usd
	us-gaap	Net Income Loss NetIncomeLoss	-200477	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-187080	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-187080	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-700029	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-383277	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2430128	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-200477	usd
CY2022Q3	tvpc	Basic And Dilutive Loss Income Per Share Of Common Stock BasicAndDilutiveLossIncomePerShareOfCommonStock	-0.10
CY2021Q3	tvpc	Basic And Dilutive Loss Income Per Share Of Common Stock BasicAndDilutiveLossIncomePerShareOfCommonStock	-0.06
	tvpc	Basic And Dilutive Loss Income Per Share Of Common Stock BasicAndDilutiveLossIncomePerShareOfCommonStock	-0.35
	tvpc	Basic And Dilutive Loss Income Per Share Of Common Stock BasicAndDilutiveLossIncomePerShareOfCommonStock	-0.04
CY2022Q3	tvpc	Weighted Average Number Of Shares Of Common Stock Outstanding WeightedAverageNumberOfSharesOfCommonStockOutstanding	7013478	shares
CY2021Q3	tvpc	Weighted Average Number Of Shares Of Common Stock Outstanding WeightedAverageNumberOfSharesOfCommonStockOutstanding	6282700	shares
	tvpc	Weighted Average Number Of Shares Of Common Stock Outstanding WeightedAverageNumberOfSharesOfCommonStockOutstanding	7004542	shares
	tvpc	Weighted Average Number Of Shares Of Common Stock Outstanding WeightedAverageNumberOfSharesOfCommonStockOutstanding	4769200	shares
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1548840	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	131949	usd
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1680789	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	50851	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1731640	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	15852037	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	86571	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-383277	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17286971	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16699700	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	224832	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1191317	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15733215	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	301891	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-538782	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15496324	usd
CY2022Q3	tvpc	Common Stock Issued For Payment On Behalf Of Parent CommonStockIssuedForPaymentOnBehalfOfParent	52400	usd
CY2022Q3	tvpc	Subsidiary Share Issuance SubsidiaryShareIssuance	14829489	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	287607	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-887109	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29778711	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2617208	usd
	us-gaap	Net Income Loss NetIncomeLoss	-200477	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	814330	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	86571	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	372511	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	132089	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-49990	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-224037	usd
	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	286271	usd
	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	288621	usd
	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	-150569	usd
	us-gaap	Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments	-10576	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3527	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	212908	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2593469	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1515118	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	596397	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	684813	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	726795	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	888465	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	81498	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	349269	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-275278	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-265600	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1012480	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	155853	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2584381	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-743435	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	6101461	usd
	tvpc	Net Sale Of Investment In Trading Marketable Securities NetSaleOfInvestmentInTradingMarketableSecurities	3002592	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	80000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2394169	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1221826	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	688423	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7323287	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15231350	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15852037	usd
	us-gaap	Deferred Finance Costs Ownshare Lending Arrangement Issuance Costs Adjustment DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsAdjustment	306361	usd
	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	608224	usd
	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	28771	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	33129	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	339576	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14896218	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16153814	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19975562	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8978908	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	13000260	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	8087092	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6975302	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	891816	usd
	us-gaap	Interest Paid Net InterestPaidNet	121284	usd
	us-gaap	Interest Paid Net InterestPaidNet	118906	usd
	tvpc	Increase In Rightofuse Asset And Lease Liability IncreaseInRightofuseAssetAndLeaseLiability	655726	usd
	tvpc	Common Stocks Issued For Payment On Behalf Of Parent CommonStocksIssuedForPaymentOnBehalfOfParent	52400	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zlYdPyeN1FM1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_862_zemjBFYT7dk8">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q3	us-gaap	Cash Cash	19975562	usd
CY2021Q4	us-gaap	Cash Cash	6975302	usd
CY2022Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	13940706	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zgkqIHZ60ja3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_86F_znTbbQNHyhCe">Concentrations of Credit and Business Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of trade receivables. Credit risk on trade receivables is mitigated as a result of the Company’s use of trade letters of credit, dealer floor plan financing arrangements, and the geographically diversified nature of the Company’s customer base. The Company minimizes the concentration of credit risk associated with its cash by maintaining its cash with high quality federally insured financial institutions. However, cash balances in excess of the Federal Deposit Insurance Corporation (“FDIC”) insured limit of $<span id="xdx_905_eus-gaap--CashFDICInsuredAmount_c20220930_pp0p0" title="FDIC insured limit">250,000</span> are at risk. As of September 30, 2022 and December 31, 2021, the Company had $<span id="xdx_90D_eus-gaap--CashUninsuredAmount_c20220930_pp0p0" title="FDIC uninsured amount">19,023,055</span> and $<span id="xdx_907_eus-gaap--CashUninsuredAmount_c20211231_pp0p0" title="FDIC uninsured amount">6,725,302</span>, respectively, in excess of FDIC insured limits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	19023055	usd
CY2021Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	6725302	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1026580	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	14100	usd
CY2022Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	4025956	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	2805739	usd
CY2022Q3	us-gaap	Marketable Securities MarketableSecurities	2910936	usd
CY2021Q4	us-gaap	Marketable Securities MarketableSecurities	6064097	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	4138044	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1518947	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	255194	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	240256	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	40566	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	4393238	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1799769	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5604905	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3344303	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	830066	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	461132	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4774839	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2883171	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	372511	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	132089	usd
CY2022Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0036	pure
CY2021Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0036	pure
	tvpc	Schedule Of Leases Supplemental Balance Sheet Information ScheduleOfLeasesSupplementalBalanceSheetInformation	<table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfLeasesSupplementalBalanceSheetInformation_zUPJLZhAFWCk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases - Related Party (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B1_zKhD4m7FOANc" style="display: none">Schedule of leases supplemental balance sheet information</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20220930_zahE7H2RCBJ5" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_493_20211231_zxFGbjmVlnig" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td> </td> <td colspan="3" style="text-align: center">September 30,</td><td> </td> <td colspan="3" style="text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td></tr> <tr id="xdx_40E_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Operating lease ROU asset</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,264,259</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">1,550,530</td><td style="width: 1%; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20220930_zXv3k0CTuaC7" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20211231_zw3JfyfCGEnl" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td> </td> <td colspan="3" style="text-align: center">September 30,</td><td> </td> <td colspan="3" style="text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2022</td><td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2021</td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeaseLiabilityAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Operating lease liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_maOLLzFJD_zgFUHrERBpp4" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Current portion</td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">387,993</td><td style="width: 1%; text-align: left"> </td><td style="width: 8%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">368,602</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_maOLLzFJD_z2woarXhAy4e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Non-current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">949,495</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,244,164</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OperatingLeaseLiability_iTI_pp0p0_mtOLLzFJD_zXMeaeeuXqF2" style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,337,488</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,612,766</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1264259	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1550530	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	387993	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	368602	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	949495	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1244164	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1337488	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1612766	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	94500	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	396900	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	416745	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	437582	usd
CY2022Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1345727	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	8239	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1337488	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0036	pure
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y2M1D
CY2022Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	172485	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	185402	usd
CY2022Q3	us-gaap	Interest Payable Current InterestPayableCurrent	49052	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	33852	usd
CY2022Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	77000	usd
CY2021Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	30000	usd
CY2021Q4	us-gaap	Accrued Exchange Fee Rebate Current AccruedExchangeFeeRebateCurrent	60000	usd
CY2022Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	73300	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	10225	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	82621	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	62335	usd
CY2022Q3	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	83854	usd
CY2021Q4	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	75000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	538312	usd
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	456814	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2171	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	8892	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	9231	usd
CY2022Q3	us-gaap	Long Term Debt Maturing In Years Two And Three LongTermDebtMaturingInYearsTwoAndThree	9583	usd
CY2022Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	470023	usd
CY2022Q3	us-gaap	Long Term Debt LongTermDebt	499900	usd
CY2022Q3	us-gaap	Due From Affiliates DueFromAffiliates	93000	usd
	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	5850	usd
CY2022Q3	us-gaap	Contractual Obligation ContractualObligation	11825000	usd
CY2021Q4	us-gaap	Contractual Obligation ContractualObligation	4273000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	2200	usd
CY2022Q3	us-gaap	Shares Issued SharesIssued	150000	shares
CY2022Q3	us-gaap	Share Price SharePrice	7.50
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	814330	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	86571	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	814330	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate	0.000	pure
	tvpc	Expected Volatility Of Option Table Textblock ExpectedVolatilityOfOptionTableTextblock	<table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ExpectedVolatilityOfOptionTableTextblock_z9runiUfv0G" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stockholder's Equity (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B8_zIGhZRTg0hvi" style="display: none">Schedule of expected volatility of option</span></td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; text-align: center">Options Outstanding</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="text-align: center">Weighted Average</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td> <td colspan="3" style="text-align: center">Number of</td> <td> </td> <td colspan="3" style="text-align: center">Weighted Average</td> <td> </td> <td colspan="3" style="text-align: center">Remaining life</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Options</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">Exercise Price</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">(years)</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td> <td colspan="3" style="text-align: center"> </td> <td> </td> <td colspan="3" style="text-align: center"> </td> <td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 39%; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2021</span></td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220930_zEcp4MmIfMle" style="width: 15%; text-align: right" title="Outstanding at beginning of period">713,612</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 5%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20220930_zLuFLaJx8PYe" style="width: 15%; text-align: right" title="Outstanding at beginning of period">5.13</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 5%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 15%; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220930_z0BvSiIAK0R5" title="Outstanding at beginning of period">9.54</span></td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td style="text-align: left"> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20220101__20220930_zkHH7sgGgLhg" style="text-align: right" title="Granted">277,500</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20220930_zH4erGhdHdJf" style="text-align: right" title="Granted">3.84</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementByGrantedSharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220930_zUbCVtDdOgt1" title="Granted">10.00</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td> <td style="text-align: left"> </td> <td id="xdx_980_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20220930_pdd" style="text-align: right" title="Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0958">—</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20220930_zcWiDIWPrWgc" style="text-align: right" title="Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0960">—</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">—</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited/canceled</span></td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20220101__20220930_z0gef3G4Xsh8" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited">(7,624</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_di_c20220101__20220930_zZVnUbRVLiil" style="border-bottom: Black 1pt solid; text-align: right" title="Forfeited">(4.10</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(<span id="xdx_903_ecustom--SharebasedCompensationArrangementByForfeitedCanceledSharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20220930_zEFrdylwWxZh" title="Forfeited">9.10</span></td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, September 30, 2022</span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220930_zgqVAUqLt6cf" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding at end of period">983,488</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20220930_zRFGyylGF4Y1" style="border-bottom: Black 2.5pt double; text-align: right" title="Outstanding at end of period">4.81</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220930_zuPjsqzoyorf" title="Outstanding at end of period">8.94</span></td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable options, September 30, 2022</span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20220930_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Exercisable at end of period">463,707</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20220930_pdd" style="border-bottom: Black 2.5pt double; text-align: right" title="Exercisable at end of period">4.81</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20220101__20220930_zosDBIn1tZR2" title="Exercisable at end of period">8.93</span></td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	713612	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.13
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y6M14D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	277500	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.84
	tvpc	Sharebased Compensation Arrangement By Granted Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementByGrantedSharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P10Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	7624	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.10
	tvpc	Sharebased Compensation Arrangement By Forfeited Canceled Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementByForfeitedCanceledSharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y1M6D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	983488	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.81
	tvpc	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P8Y11M8D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	463707	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.81
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y11M4D
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	519781	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	683500	shares
	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate	0.000	pure
	us-gaap	Revenues Revenues	23217634	usd
	us-gaap	Cost Of Revenue CostOfRevenue	14001994	usd
	us-gaap	Operating Expenses OperatingExpenses	11592732	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2377092	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-240116	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2617208	usd
	us-gaap	Revenues Revenues	10623460	usd
	us-gaap	Cost Of Revenue CostOfRevenue	6209334	usd
	us-gaap	Operating Expenses OperatingExpenses	4698831	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-284705	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	84228	usd
	us-gaap	Net Income Loss NetIncomeLoss	-200477	usd
CY2022Q3	us-gaap	Revenues Revenues	8812021	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	5477947	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	4191034	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-856960	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-30149	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-887109	usd
CY2021Q3	us-gaap	Revenues Revenues	4118246	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	2508170	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	1932610	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-322534	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-60743	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-383277	usd

Files In Submission

Name	View Source	Status
0001731122-22-001893-index-headers.html	Edgar Link	pending
0001731122-22-001893-index.html	Edgar Link	pending
0001731122-22-001893.txt	Edgar Link	pending
0001731122-22-001893-xbrl.zip	Edgar Link	pending
e4206_10-q.htm	Edgar Link	pending
e4206_ex31-1.htm	Edgar Link	pending
e4206_ex31-2.htm	Edgar Link	pending
e4206_ex32-1.htm	Edgar Link	pending
e4206_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tvpc-20220930.xsd	Edgar Link	pending
tvpc-20220930_def.xml	Edgar Link	unprocessable
tvpc-20220930_lab.xml	Edgar Link	unprocessable
tvpc-20220930_pre.xml	Edgar Link	unprocessable
e4206_10-q_htm.xml	Edgar Link	completed
tvpc-20220930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VEEE
Twin Vee PowerCats, Co. Stock $veee

2022 Q4 Form 10-Q Financial Statement

#000173112222001893 Filed on November 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VEEE Twin Vee PowerCats, Co. Stock $veee

2022 Q4 Form 10-Q Financial Statement

#000173112222001893 Filed on November 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VEEE
Twin Vee PowerCats, Co. Stock $veee